The use of an anti-IL-17 antibody also delayed the progression of lung metastasis in a T-bet knockout mouse model of lung adenocarcinoma after the injection of LLC cells into the tail vein [41]. This evidence concerns the gene IL17A and lung adenocarcinoma.